Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
par
Rugo, Hope H.S.
, Tolaney, Sara S.M.
, Loirat, Delphine
, Punie, Kevin
, Bardia, Aditya
, Hurvitz, Sara
, O'Shaughnessy, Joyce
, Cortes, Javier
, Diéras, Veronique
, Carey, Lisa L.A.
, Gianni, Luca
, Piccart-Gebhart, Martine
, Loibl, Sibylle
, Goldenberg, David D.M.
, Hong, Quan
, Olivo, Martin M.S.
, Itri, Loretta Marie
, Kalinsky, Kevin
Publication
2022-12
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
par
Bardia, Aditya
, Tolaney, Sara S.M.
, Punie, Kevin
, Loirat, Delphine
, Oliveira, Mafalda
, Kalinsky, Kevin
, Zelnak, Amelia A.B.
, Aftimos, Philippe
, Dalenc, Florence
, Sardesai, Sagar S.D.
, Hamilton, Erika
, Sharma, Priyanka
, Recalde, Sabela
, Gil, E.C.
, Traina, Tiffany T.A.
, O'Shaughnessy, Joyce
, Cortes, Javier
, Tsai, Meng Han
, Vahdat, Linda L.T.
, Diéras, Veronique
, Carey, Lisa L.A.
, Rugo, Hope H.S.
, Goldenberg, David D.M.
, Hong, Quang QT
, Olivo, Martin M.S.
, Itri, Loretta Marie
, Hurvitz, Sara
Publication
2021